Ian Hardy

Company: Miltenyi Biotec B.V. & Co. KG

Job title: Director Preclinical & Translational T Cell Therapy

Seminars:

Clinical-scale selection & expansion of GBM tumor-reactive T cells using the CliniMACS Prodigy TRT Process 4:00 pm

CliniMACS Prodigy TRT system is a GMP compliant TIL manufacturing platform Automated CD137+ selection and enrichment of GBM-TRTs at clinical scale CD137+ selected GBM-TRTs have significantly enhanced tumor reactivityRead more

day: Conference Day One